Altered PLCβ/IP3/Ca2+ Signaling Pathway Activated by GPRCs in Olfactory Neuronal Precursor Cells Derived from Patients Diagnosed with Schizophrenia
- PMID: 39457654
- PMCID: PMC11504003
- DOI: 10.3390/biomedicines12102343
Altered PLCβ/IP3/Ca2+ Signaling Pathway Activated by GPRCs in Olfactory Neuronal Precursor Cells Derived from Patients Diagnosed with Schizophrenia
Abstract
Background: Schizophrenia (SZ) is a multifactorial chronic psychiatric disorder with a worldwide prevalence of 1%. Altered expression of PLCβ occurs in SZ patients, suggesting alterations in the PLCβ/IP3/Ca2+ signaling pathway. This cascade regulates critical cellular processes in all cell types, including the neuronal lineage; however, there is scarce evidence regarding the functionality of this transduction signaling in neuronal cells derived from SZ patients. Objective: We evaluated the functionality of the PLCβ/IP3/Ca2+ pathway in olfactory neuronal precursor cells (hONPCs) obtained from SZ patients. Methods: Cryopreserved hONPCs isolated from SZ patients and healthy subjects (HS) were thawed. The cellular types in subcultures were corroborated by immunodetection of the multipotency and lineage markers SOX-2, Musashi-1, nestin, and β-III tubulin. The PLCβ/IP3/Ca2+ pathway was activated by GPCR (Gq) ligands (ATP, UTP, serotonin, and epinephrine). In addition, PLCβ and IP3R were directly stimulated by perfusing cells with the activators m-3M3FBS and ADA, respectively. Cytosolic Ca2+ was measured by microfluorometry and by Ca2+ imaging. The amount and subcellular distribution of the PLCβ1 and PLCβ3 isoforms were evaluated by confocal immunofluorescence. IP3 concentration was measured by ELISA. Results: The results show that the increase of cytosolic Ca2+ triggered by GPCR ligands or directly through either PLCβ or IP3R activation was significantly lower in SZ-derived hONPCs, regarding HS-derived cells. Moreover, the relative amount of the PLCβ1 and PLCβ3 isoforms and IP3 production stimulated with m-3M3FBS were reduced in SZ-derived cells. Conclusions: Our results suggest an overall functional impairment in the PLCβ/IP3/Ca2+ signaling pathway in SZ-derived hONPCs.
Keywords: IP3; PLCβ; calcium signaling; human olfactory neuronal stem cells; schizophrenia.
Conflict of interest statement
The authors have declared that there are no conflicts of interest concerning the subject of this study.
Figures








Similar articles
-
Functional cooperation between the IP3 receptor and phospholipase C secures the high sensitivity to light of Drosophila photoreceptors in vivo.J Neurosci. 2015 Feb 11;35(6):2530-46. doi: 10.1523/JNEUROSCI.3933-14.2015. J Neurosci. 2015. PMID: 25673847 Free PMC article.
-
Activation of PLCβ1 enhances endocannabinoid mobilization to restore hippocampal spike-timing-dependent potentiation and contextual fear memory impaired by Alzheimer's amyloidosis.Alzheimers Res Ther. 2021 Oct 8;13(1):165. doi: 10.1186/s13195-021-00901-9. Alzheimers Res Ther. 2021. PMID: 34625112 Free PMC article.
-
Molecular regulation of PLCβ signaling.Methods Enzymol. 2023;682:17-52. doi: 10.1016/bs.mie.2023.01.001. Epub 2023 Feb 22. Methods Enzymol. 2023. PMID: 36948701 Free PMC article. Review.
-
Gβγ subunit inhibitor decreases DOM-induced head twitch response via the PLCβ/IP3/Ca2+/ERK and cAMP signaling pathways.Eur J Pharmacol. 2023 Oct 15;957:176038. doi: 10.1016/j.ejphar.2023.176038. Epub 2023 Aug 30. Eur J Pharmacol. 2023. PMID: 37657742
-
Potential of olfactory neuroepithelial cells as a model to study schizophrenia: A focus on GPCRs (Review).Int J Mol Med. 2024 Jan;53(1):7. doi: 10.3892/ijmm.2023.5331. Epub 2023 Dec 1. Int J Mol Med. 2024. PMID: 38038161 Free PMC article. Review.
Cited by
-
Stem cell therapy for the treatment of psychiatric disorders: a real hope for the next decades.Front Psychiatry. 2025 Jan 7;15:1492415. doi: 10.3389/fpsyt.2024.1492415. eCollection 2024. Front Psychiatry. 2025. PMID: 39839136 Free PMC article. Review.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous